October 21, 2022
Guerbet: Revenue at September 30, 2022
Revenue on September 30, 2022 Faster growth in Q3 2022 Revenue: +5.1% at CER1 (€187 million)Very dynamic activity in Asia (+18.4%) and within MRI…
Pharmaceuticals, Biotechnology and Life Sciences
Revenue on September 30, 2022 Faster growth in Q3 2022 Revenue: +5.1% at CER1 (€187 million)Very dynamic activity in Asia (+18.4%) and within MRI…
WOBURN, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of…
LEXINGTON, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of…
WOODCLIFF LAKE, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced…
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, the “Company”), a clinical stage…
BALA CYNWYD, Pa., Oct. 19, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…
ZUG, Switzerland, Oct. 19, 2022 (GLOBE NEWSWIRE) — Covis Pharma Group (the “Company”), today reported that the Obstetrics, Reproductive, and Urologic…
VANCOUVER, BC, CANADA, Oct. 19, 2022 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower…
RESEARCH TRIANGLE PARK, N.C., Oct. 19, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will…